Literature DB >> 23458672

Memantine protects cholinergic and glutamatergic septal neurons from Aβ1-40-induced toxicity.

L V Colom1, M T Castaneda, D Aleman, A Touhami.   

Abstract

The medial septal region (medial septum and diagonal band of Broca, MS/DB) controls hippocampal excitability and synaptic plasticity. MS/DB cholinergic neurons degenerate early in Alzheimer's disease (AD). The presence of MS/DB glutamatergic neurons that project to the hippocampus and are vulnerable to Aβ suggests that excitotoxicity plays a role in AD septal degeneration and hippocampal dysfunction. To demonstrate the presence of excitotoxicity in Aβ-induced septal damage, we compared rats injected with Aβ1-40 into the MS/DB with animals treated with memantine prior, during and after Aβ1-40 injections. Controls were injected with phosphate buffered saline (PBS). MS/DB cholinergic, glutamatergic and GABAergic neurons were immunochemically identified. The number of MS/DB neurons was estimated using stereology. Our results show that memantine blocks Aβ1-40-induced septal damage and suggest that excitotoxicity plays a role in basal forebrain neurodegeneration. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23458672      PMCID: PMC3631469          DOI: 10.1016/j.neulet.2013.02.010

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  26 in total

1.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

2.  N-Methyl-D-aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neurons against beta-amyloid neurotoxicity.

Authors:  T Harkany; J Mulder; M Sasvári; I Abrahám; C Kónya; M Zarándi; B Penke; P G Luiten; C Nyakas
Journal:  Neurobiol Dis       Date:  1999-04       Impact factor: 5.996

3.  The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-β42 with memantine.

Authors:  Csaba Nyakas; Ivica Granic; László G Halmy; Pradeep Banerjee; Paul G M Luiten
Journal:  Behav Brain Res       Date:  2010-05-27       Impact factor: 3.332

4.  Low doses of memantine disrupt memory in adult rats.

Authors:  Catherine Creeley; David F Wozniak; Joanne Labruyere; George T Taylor; John W Olney
Journal:  J Neurosci       Date:  2006-04-12       Impact factor: 6.167

Review 5.  Pathologically activated therapeutics for neuroprotection.

Authors:  Stuart A Lipton
Journal:  Nat Rev Neurosci       Date:  2007-10       Impact factor: 34.870

6.  Medial septal beta-amyloid 1-40 injections alter septo-hippocampal anatomy and function.

Authors:  Luis V Colom; Maria T Castañeda; Cristina Bañuelos; Gustavo Puras; Antonio García-Hernández; Sofia Hernandez; Suzanne Mounsey; Joy Benavidez; Claudia Lehker
Journal:  Neurobiol Aging       Date:  2008-06-10       Impact factor: 4.673

7.  Memantine acts as a cholinergic stimulant in the mouse hippocampus.

Authors:  Benjamin D Drever; William G L Anderson; Helena Johnson; Matthew O'Callaghan; Sangwon Seo; Deog-Young Choi; Gernot Riedel; Bettina Platt
Journal:  J Alzheimers Dis       Date:  2007-12       Impact factor: 4.472

Review 8.  Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse.

Authors:  Chris G Parsons; Albrecht Stöffler; Wojciech Danysz
Journal:  Neuropharmacology       Date:  2007-08-10       Impact factor: 5.250

9.  Effects of beta-amyloid protein on serotoninergic, noradrenergic, and cholinergic markers in neurons of the pontomesencephalic tegmentum in the rat.

Authors:  A Gonzalo-Ruiz; I González; J M Sanz-Anquela
Journal:  J Chem Neuroanat       Date:  2003-11       Impact factor: 3.052

10.  Pharmacodynamics of memantine: an update.

Authors:  G Rammes; W Danysz; C G Parsons
Journal:  Curr Neuropharmacol       Date:  2008-03       Impact factor: 7.363

View more
  2 in total

1.  Thymoquinone prevents β-amyloid neurotoxicity in primary cultured cerebellar granule neurons.

Authors:  Norsharina Ismail; Maznah Ismail; Musalmah Mazlan; Latiffah Abdul Latiff; Mustapha Umar Imam; Shahid Iqbal; Nur Hanisah Azmi; Siti Aisyah Abd Ghafar; Kim Wei Chan
Journal:  Cell Mol Neurobiol       Date:  2013-10-08       Impact factor: 5.046

2.  Impaired NGF/TrkA Signaling Causes Early AD-Linked Presynaptic Dysfunction in Cholinergic Primary Neurons.

Authors:  Valentina Latina; Silvia Caioli; Cristina Zona; Maria T Ciotti; Giuseppina Amadoro; Pietro Calissano
Journal:  Front Cell Neurosci       Date:  2017-03-15       Impact factor: 5.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.